NDC 73309-063-01 - Amantadine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-063
- Requested NDC
- 73309-063-01
- Package NDCs from labels
- 73309-063-01
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2019-12-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amantadine Hydrochloride - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2019-12-02 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-063-01 | Amantadine Hydrochloride | 500 g in 1 JAR | POWDER | 500 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | ST. MARY'S MEDICAL PARK PHARMACY | 3dd7f2a6-5a91-81a2-e063-6294a90a33db | 2025-09-02 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| AMANTADINE HYDROCHLORIDE | AMANTADINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | be411327-5ac7-46df-b5e4-32a11b419b15 | 2025-08-07 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine | AMANTADINE | Alembic Pharmaceuticals Inc. | da1837b5-fda2-48e0-91ba-d6eb2b991b55 | 2025-07-28 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| amantadine hydrochloride | AMANTADINE HYDROCHLORIDE | Bryant Ranch Prepack | 8e578f11-6112-4a1f-8de4-a76870bb62c7 | 2025-07-14 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | Advagen Pharma Limited | c3b9e7f0-be6d-4f37-9277-54bb0ba8b158 | 2025-07-09 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | Upsher-Smith Laboratories, LLC | 5232b933-1df9-43b4-8ac2-61bfa4855e68 | 2025-07-09 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| AMANTADINE HYDROCHLORIDE | AMANTADINE HYDROCHLORIDE | BAJAJ MEDICAL, LLC | 38fccce5-1f1e-9350-e063-6394a90a045a | 2025-07-02 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | Bryant Ranch Prepack | e3eb34af-6e25-4a3d-a7d2-e9a789e335cc | 2025-06-26 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine HCl | AMANTADINE HYDROCHLORIDE | AvPAK | 461e6444-189e-62ed-6c61-1c36a04459c6 | 2025-06-24 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine HCl | AMANTADINE HYDROCHLORIDE | AvKARE | bfd129ae-8b0a-f118-b7d0-45d106290b63 | 2025-06-24 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine HCl | AMANTADINE HYDROCHLORIDE | Bionpharma Inc. | d6ca4d20-72c5-496c-9ac7-1f5cb407a742 | 2025-06-09 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| amantadine hydrochloride | AMANTADINE HYDROCHLORIDE | EPIC PHARMA LLC | 0f70c79a-92a4-4a38-bbdd-900adc4c2e93 | 2025-06-06 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 1b9498b7-125e-4314-baca-b62af6e5511c | 2025-06-06 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine Hydrochloride | AMANTADINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 6fd54e00-a714-4442-af95-2515ab3b2ac3 | 2025-06-04 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| amantadine | AMANTADINE | Alembic Pharmaceuticals Inc. | 4157d9a7-a53f-4dde-b051-fe3e9a674913 | 2025-06-04 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| amantadine hydrochloride | AMANTADINE HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 609dc911-1e9d-4ebd-b64b-f44054e5582e | 2025-06-04 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| amantadine hydrochloride | AMANTADINE HYDROCHLORIDE | Zydus Lifesciences Limited | 579e6c23-6286-4b80-88de-c86c0e5cc2b2 | 2025-06-04 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine | AMANTADINE | Xttrium Laboratories, Inc | 25dd8a3c-6b11-2ea1-e063-6294a90a50cf | 2025-05-21 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| AMANTADINE HYDROCHLORIDE | AMANTADINE HYDROCHLORIDE | ATLANTIC BIOLOGICALS CORP. | 6311b46b-23cc-40c1-93c2-f7c92606386f | 2025-05-12 | Warnings, Adverse reactions | M6Q1EO9TD0 |
| Amantadine | AMANTADINE | Coupler LLC | 303c5b9d-5761-9fcd-e063-6394a90a8a2b | 2025-03-13 | Warnings, Adverse reactions | M6Q1EO9TD0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.